M
Micah L. Thorp
Researcher at Kaiser Permanente
Publications - 48
Citations - 1959
Micah L. Thorp is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 20, co-authored 48 publications receiving 1729 citations. Previous affiliations of Micah L. Thorp include Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
Brad C. Astor,Kunihiro Matsushita,Ron T. Gansevoort,Marije van der Velde,Mark Woodward,Andrew S. Levey,Paul E. de Jong,Josef Coresh,Meguid El-Nahas,Kai-Uwe Eckardt,Bertram L. Kasiske,Jackson T. Wright,Lawrence J. Appel,Tom Greene,Adeera Levin,Ognjenka Djurdjev,David C. Wheeler,Martin J Landray,John N. Townend,Jonathan Emberson,Laura E Clark,Alison M. MacLeod,Angharad Marks,Tariq Ali,Nicholas Fluck,Gordon Prescott,David H. Smith,Jessica R. Weinstein,Eric S. Johnson,Micah L. Thorp,Jack F.M. Wetzels,Peter J. Blankestijn,A D van Zuilen,Vandana Menon,Mark J. Sarnak,Gerald J. Beck,Florian Kronenberg,Barbara Kollerits,Marc Froissart,Bénédicte Stengel,Marie Metzger,Giuseppe Remuzzi,Piero Ruggenenti,Annalisa Perna,H. J. Lambers Heerspink,Barry M. Brenner,Dick de Zeeuw,Peter Rossing,Hans-Henrik Parving,Priscilla Auguste,Kasper Veldhuis,Yaping Wang,Laura Camarata,Beverly Thomas,Tom Manley +54 more
TL;DR: Lower eGFR and more severe albuminuria independently predict mortality and ESRD among individuals selected for CKD, with the associations stronger for E SRD than for mortality.
Journal ArticleDOI
A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients.
TL;DR: Gabapentin is an effective treatment for RLS in hemodialysis patients in a randomized, double-blind, placebo-crossover study of gabapentin in the treatment of RLS.
Journal ArticleDOI
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol.
TL;DR: If carefully monitored, patients suffering adverse effects secondary to cyclosporine may be converted to tacrolimus with minimal risk of allograft dysfunction or rejection.
Journal ArticleDOI
Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction The Cardiovascular Research Network PRESERVE Study
David H. Smith,Micah L. Thorp,Jerry H. Gurwitz,David D. McManus,Robert J. Goldberg,Larry A. Allen,Grace Hsu,Sue Hee Sung,David J. Magid,Alan S. Go +9 more
TL;DR: CKD is common and an important independent predictor of death and hospitalization in adults with HF across the spectrum of left ventricular systolic function and the need to develop new and effective interventions for the growing number of patients with HF complicated by CKD is highlighted.
Journal ArticleDOI
Predicting the Risk of Dialysis and Transplant Among Patients With CKD: A Retrospective Cohort Study
TL;DR: A risk score to predict the 5-year risk of renal replacement therapy (RRT) in patients with stage 3 or 4 CKD can help providers identify patients with CKD at the highest risk of progression to improve referral to nephrology for comanagement.